Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Myhre Syndrome Foundation



Address

25 Creekwood Circle,
Richardson, TX 75080 USA

Email Address

[email protected]

Description

 Myhre Syndrome Foundation is dedicated to serving Myhre syndrome families by providing a network of hope and support and collaborating with scientific and medical communities to encourage and fund promising research. Our goals are simple – To educate the public and the medical community to ensure early diagnosis and proper treatment; To promote safe and effective treatments through advocacy, research funding and a comprehensive patient registry; To provide a caring and supporting community for Myhre patients and families. Facebook: https://www.facebook.com/myhresyndromefoundation Twitter: https://twitter.com/myhresyndrome

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.